Autor(es): Silva,Denise Rossato ; Mello,Fernanda Carvalho de Queiroz ; D’Ambrosio,Lia ; Centis,Rosella ; Dalcolmo,Margareth Pretti ; Migliori,Giovanni Battista
Data: 2021
Origem: Oasisbr
Assunto(s): Tuberculosis; COVID-19; SARS-CoV-2; Coronavirus
Autor(es): Silva,Denise Rossato ; Mello,Fernanda Carvalho de Queiroz ; D’Ambrosio,Lia ; Centis,Rosella ; Dalcolmo,Margareth Pretti ; Migliori,Giovanni Battista
Data: 2021
Origem: Oasisbr
Assunto(s): Tuberculosis; COVID-19; SARS-CoV-2; Coronavirus
ABSTRACT On April 1st, 2020, COVID-19 surpassed tuberculosis regarding the number of deaths per day worldwide. The combination of tuberculosis and COVID-19 has great potential for morbidity and mortality. In addition, the COVID-19 pandemic has had a significant impact on the diagnosis and treatment of tuberculosis. In this review article, we address concurrent tuberculosis and COVID-19, with particular regard to the differences between Brazil and Europe. In addition, we discuss priorities in clinical care, public health, and research.